Skip to main content
. Author manuscript; available in PMC: 2015 Sep 29.
Published in final edited form as: Care Manag J. 2015;16(3):122–128. doi: 10.1891/1521-0987.16.3.122

Table 2.

Psychotropic medication use among homebound patients receiving HBPC (n=802)

Drug or Drug Combination Count %
Alzheimer’s dementia medication use NMDA antagonist and/or cholinesterase inhibitors 110 13.7%
Alzheimer’s medication & Antipsychotic/anticonvulsant 49 6.1%
Antidepressant use At least 1 Antidepressant 335 41.7%
More than 1 antidepressants 35 4.4%
Type: Antidepressant-SSRI 213 26.5%
Type: Antidepressant-tricyclic 13 1.6%
Type: Antidepressant-other 161 20%
Antidepressant & Antipsychotics 102 12.7%
Antidepressant & Anxiolytic 59 7.4%
Anxiolytic use Any Anxiolytic 94 11.7%
Type: Anxiolytic/Hypnotic-Benzodiazepines 43 5.4%
Type: Anxiolytic/Hypnotic-Other 56 7%
Other psychiatric medications Anti-mania Agents 10 1.2%
Antipsychotics 173 21.52%